Skip Navigation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Sarkozy, A.
Right arrow Articles by Brugada, J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Sarkozy, A.
Right arrow Articles by Brugada, J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2007. For permissions please email: journals.permissions@oxfordjournals.org

Optimizing the clinical use of implantable defibrillators in patients with Brugada syndrome

Andrea Sarkozy1,*, Pedro Brugada1, Lluis Mont2 and Josep Brugada2

1 Heart Rhythm Management Institute, Vrije Universiteit Brussel, Laarbeeklaan 101, 1090-B Brussels, Belgium
2 Cardiology Department, Thorax Institute, University of Barcelona, Barcelona, Spain

* Corresponding author. Tel: +32 2477 6010; fax: +32 2477 6840. E-mail address: andreasarkozy{at}yahoo.ca

Our review highlights the difficulties we face when treating patients with Brugada syndrome (BS) by an implantable cardioverter defibrillator (ICD). Higher defibrillation thresholds, high inappropriate shock rates because of sinus tachycardia and supraventricular tachycardias, T wave oversensing, and high lead failure rates should be expected. Psychosocial adjustment problems also occur frequently in this patient population. These high complications rates are because of specific characteristics of the BS patient population, consisting of young, active patients with a primary electrical disease. The management strategies include prevention and early recognition of the expected complications. Additionally, individualized careful programming of the ICD is essential to ensure maximal safety and minimal complication rates in patients with BS.

Key Words: Brugada syndrome • Implantable cardioverter defibrillator • Ventricular tachyarrhythmias


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.